Level C· Early human research exploring benefitsProspective StudyEurope PMCOpen access

Strategies and challenges in developing pre-vascularized three-dimensional skin substitutes using layer-by-layer cell coating technology

Tsunoi Y., Miyazaki H.

Prospective Study on Face & Skin, published in Regen Ther (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Regen Ther (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42064170
PMCID
PMC13126850
DOI
10.1016/j.reth.2026.101108

Abstract (original English)

Irreversible cutaneous injuries must be treated by skin transplantation. Autologous skin grafts are the gold standard; however, donor sites are often limited in patients with extensive injuries. Conventional artificial skin substitutes are also effective in several clinical cases. However, a major limitation is the lack of vascular structures, which results in delayed perfusion, increased risk of infection, and engraftment failure, especially in intractable wounds. To address this challenge, various advanced tissue engineering technologies have been explored to develop novel three-dimensional (3D) skin substitutes with vascular networks. In this review, we first discuss recent progress in the development of tissue-engineered 3D skin models. In particular, we highlight a 3D culture technique based on the layer-by-layer (LbL) method, which forms ultrathin films of extracellular matrix proteins on cell surfaces and promotes the self-assembly of cells. We also describe the developmental history of the LbL method for fabricating 3D biological tissue models, including skin constructs. Furthermore, we introduce our original application of photobiomodulation (PBM), an optical activation method, to LbL-3D skin during cultivation. Finally, we present the results of transplanting LbL-3D skin onto a mouse wound model and discuss the future prospects for this skin substitute.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research